“Genomic Medicine in Internal Medicine Practice” (Hybrid Event)

Ali Gharavi, MD
Professor of Nephrology and Hypertension
Chief, Division of Nephrology
Interim Chair, Department of Medicine

Ali Gharavi, M.D., is the Jay Meltzer M.D. Professor of Nephrology and Hypertension and serves as Chief of the Division of Nephrology, Director of the Center for Precision and Genomics in the Department of Medicine and Interim Chair of the Department of Medicine. After receiving his medical degree from George Washington University, Dr. Gharavi completed residency in internal medicine and fellowships in hypertension and nephrology at the Mount Sinai Medical Center. He then completed a postdoctoral fellowship in human genetics at Yale University and joined Columbia University in 2003. Dr. Gharavi’s research is focused on the molecular genetics of kidney diseases and his work has led to the discovery of genes and loci for IgA nephropathy and congenital defects of the kidney and urinary tract. His research has demonstrated the utility of clinical sequencing in the diagnosis and management of patients with kidney disease and he is extending this work to other adult constitutional disorders. His goal is to bring personalized genomic medicine from the laboratory into patient care. He is the principal investigator of multiple scientific projects funded by the National Institute of Health, including the All of Us grant, the national precision medicine initiative. He was elected to the American Society of Clinical Investigation and the American Association of Physicians. He is a recipient of the Judson Daland Prize for Outstanding Clinical Investigation from the American Philosophical Society, the National Medical Award, from the Kidney and Urology Foundation of America and the Homer Smith Award from the American Society of Nephrology. He also received the mentor of the year award at Columbia University.

___________________________________________________________________

Join Meeting!

OBJECTIVES:

• Analyze recent progress in genomic technology
• Illustrate application of genomic medicine to clinical care
• Explain future application of genomic medicine in clinical practice

FACULTY DISCLOSURES:

Dr. Gharavi has indicated the following relevant financial relationships with commercial interests:

Financial Relationship                                          Commercial Interest/Organization
Consultant/Contractor                                            Natera and Actio Biosciences
Individual Stock                                                      Actio Biosciences

PLANNING COMMITTEE DISCLOSURE:

Dr. Deshpande has indicated that he has no relevant financial relationships with commercial interests.
Dr. Weiss has indicated the following relevant financial relationships with commercial interests:

Financial Relationship                                          Commercial Interest/Organization
Consultant/Contractor                                             Prizm LLC

All the relevant financial relationships for these individuals have been mitigated.

TARGET AUDIENCE:
Primary care physicians.

ACCREDITATION:
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION:
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.